Alejandro Medina

473 total citations
15 papers, 105 citations indexed

About

Alejandro Medina is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Alejandro Medina has authored 15 papers receiving a total of 105 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 8 papers in Hematology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Alejandro Medina's work include Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Multiple Myeloma Research and Treatments (5 papers). Alejandro Medina is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Multiple Myeloma Research and Treatments (5 papers). Alejandro Medina collaborates with scholars based in Spain, United States and Italy. Alejandro Medina's co-authors include Cristina Jiménez, Ramón García‐Sánz, María Eugenia Sarasquete, Verónica González‐Calle, Marcos González, Carmen Chillón, Miguel Alcoceba, María García‐Álvarez, Noemí Puig and Ana Balanzategui and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and British Journal of Haematology.

In The Last Decade

Alejandro Medina

14 papers receiving 104 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alejandro Medina Spain 6 45 40 40 32 32 15 105
Stefan Köhrer Austria 4 69 1.5× 54 1.4× 32 0.8× 41 1.3× 42 1.3× 11 153
Chengqing Wu United States 7 46 1.0× 30 0.8× 25 0.6× 23 0.7× 46 1.4× 16 102
André Bortolini Silveira Brazil 5 69 1.5× 14 0.3× 35 0.9× 24 0.8× 28 0.9× 5 120
Sven Turkalj United Kingdom 5 47 1.0× 31 0.8× 34 0.8× 40 1.3× 31 1.0× 9 114
Chenglu Yuan China 5 36 0.8× 30 0.8× 74 1.9× 26 0.8× 22 0.7× 16 118
Catalina Amador United States 7 39 0.9× 64 1.6× 27 0.7× 17 0.5× 46 1.4× 19 132
Gaddy Getz United States 2 48 1.1× 27 0.7× 43 1.1× 34 1.1× 20 0.6× 3 118
Gulrukh Ahsan United Kingdom 4 36 0.8× 22 0.6× 28 0.7× 34 1.1× 24 0.8× 5 94
Barbara Mankel Germany 6 43 1.0× 76 1.9× 18 0.5× 36 1.1× 72 2.3× 12 131
Christina Ganster Germany 8 59 1.3× 30 0.8× 64 1.6× 47 1.5× 13 0.4× 17 147

Countries citing papers authored by Alejandro Medina

Since Specialization
Citations

This map shows the geographic impact of Alejandro Medina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Medina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Medina more than expected).

Fields of papers citing papers by Alejandro Medina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Medina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Medina. The network helps show where Alejandro Medina may publish in the future.

Co-authorship network of co-authors of Alejandro Medina

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Medina. A scholar is included among the top collaborators of Alejandro Medina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Medina. Alejandro Medina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Medina, Alejandro, et al.. (2025). Prevalence of Human Leukocyte Antigen (HLA)‐B*58:01 and Allopurinol‐Induced Adverse Reactions in Filipino Patients in Hawai'i: Implications for Genotyping. International Journal of Rheumatic Diseases. 28(2). e70127–e70127.
2.
García‐Álvarez, María, Cristina Jiménez, Alejandro Medina, et al.. (2023). Single-Cell DNA Sequencing and Immunophenotypic Profiling to Track Clonal Evolution in an Acute Myeloid Leukemia Patient. Biomedicines. 12(1). 66–66. 2 indexed citations
3.
Agathangelidis, Andreas, Apostolia Papalexandri, Alejandro Medina, et al.. (2023). Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories. Frontiers in Oncology. 13. 1123029–1123029. 5 indexed citations
4.
Medina, Alejandro, María Eugenia Sarasquete, Cristina Jiménez, Noemí Puig, & Ramón García‐Sánz. (2023). Minimal Residual Disease in Multiple Myeloma: Past, Present, and Future. Cancers. 15(14). 3687–3687. 17 indexed citations
5.
García‐Sánz, Ramón, María García‐Álvarez, Alejandro Medina, et al.. (2023). Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level. Disease Models & Mechanisms. 16(8). 2 indexed citations
6.
Alcoceba, Miguel, María García‐Álvarez, Alejandro Medina, et al.. (2022). MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies. International Journal of Molecular Sciences. 23(10). 5570–5570. 25 indexed citations
7.
Genuardi, Elisa, Simone Ferrero, O. J. H. M. Verhagen, et al.. (2022). Genotyping and Minimal Residual Disease (MRD) Assessment in cfDNA By the Euroclonality-NGS DNA Capture (EC-NDC) Panel in Mantle Cell Lymphoma (MCL). Blood. 140(Supplement 1). 3518–3520. 1 indexed citations
8.
Medina, Alejandro, Cristina Jiménez, Noemí Puig, et al.. (2021). Interlaboratory Analytical Validation of a Next-Generation Sequencing Strategy for Clonotypic Assessment and Minimal Residual Disease Monitoring in Multiple Myeloma. Archives of Pathology & Laboratory Medicine. 146(7). 862–871. 5 indexed citations
9.
Alcoceba, Miguel, María García‐Álvarez, Carmen Chillón, et al.. (2021). Liquid biopsy: a non‐invasive approach for Hodgkin lymphoma genotyping. British Journal of Haematology. 195(4). 542–551. 15 indexed citations
10.
Giné, Eva, Ana Jiménez Ubieto, Javier López Jiménez, et al.. (2021). EFFICACY AND SAFETY OF IBRUTINIB IN COMBINATION WITH RITUXIMAB AS FRONTLINE TREATMENT FOR INDOLENT CLINICAL FORMS OF MANTLE CELL LYMPHOMA. RESULTS OF THE GELTAMO IMCL‐2015 STUDY. Hematological Oncology. 39(S2). 1 indexed citations
11.
Jiménez, Cristina, María García‐Álvarez, Fernando Ramos, et al.. (2020). Identification of relapse‐associated gene mutations by next‐generation sequencing in low‐risk acute myeloid leukaemia patients. British Journal of Haematology. 189(4). 718–730. 8 indexed citations
12.
Corchete, Luís A., María García‐Álvarez, Cristina Jiménez, et al.. (2019). A New Next-Generation Sequencing Strategy for the Simultaneous Analysis of Mutations and Chromosomal Rearrangements at DNA Level in Acute Myeloid Leukemia Patients. Journal of Molecular Diagnostics. 22(1). 60–71. 10 indexed citations
13.
García‐Álvarez, María, Sara Alonso, Cristina Jiménez, et al.. (2019). Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas. Blood Cancer Journal. 9(7). 52–52. 10 indexed citations
14.
Medina, Alejandro, Cristina Jiménez, María Eugenia Sarasquete, et al.. (2018). VDJH Gene Repertoire Analysis in Multiple Myeloma (MM) Patients: Correlation with Clinical Data. Blood. 132(Supplement 1). 4446–4446. 1 indexed citations
15.
Agathangelidis, Andreas, Apostolia Papalexandri, Alejandro Medina, et al.. (2016). Distinct Immunogenetic Signatures in IgA Versus IgG Multiple Myeloma. Blood. 128(22). 2062–2062. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Köhrer Breakdown of academic impact, for papers by Chengqing Wu Breakdown of academic impact, for papers by André Bortolini Silveira Breakdown of academic impact, for papers by Sven Turkalj Breakdown of academic impact, for papers by Chenglu Yuan Breakdown of academic impact, for papers by Catalina Amador Breakdown of academic impact, for papers by Gaddy Getz Breakdown of academic impact, for papers by Gulrukh Ahsan Breakdown of academic impact, for papers by Barbara Mankel Breakdown of academic impact, for papers by Christina Ganster
Rankless by CCL
2026